These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16085416)

  • 1. Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7.
    Hu Y; Ma L; Wu M; Wong MS; Li B; Corral S; Yu Z; Nomanbhoy T; Alemayehu S; Fuller SR; Rosenblum JS; Rozenkrants N; Minimo LC; Ripka WC; Szardenings AK; Kozarich JW; Shreder KR
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4239-42. PubMed ID: 16085416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POP.
    Tran T; Quan C; Edosada CY; Mayeda M; Wiesmann C; Sutherlin D; Wolf BB
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1438-42. PubMed ID: 17174090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boro-norleucine as a P1 residue for the design of selective and potent DPP7 inhibitors.
    Shreder KR; Wong MS; Corral S; Yu Z; Winn DT; Wu M; Hu Y; Nomanbhoy T; Alemayehu S; Fuller SR; Rosenblum JS; Kozarich JW
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4256-60. PubMed ID: 16084722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.
    Wu W; Liu Y; Milo LJ; Shu Y; Zhao P; Li Y; Woznica I; Yu G; Sanford DG; Zhou Y; Poplawski SE; Connolly BA; Sudmeier JL; Bachovchin WW; Lai JH
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5536-40. PubMed ID: 22853995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity.
    Edosada CY; Quan C; Tran T; Pham V; Wiesmann C; Fairbrother W; Wolf BB
    FEBS Lett; 2006 Mar; 580(6):1581-6. PubMed ID: 16480718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides.
    Coutts SJ; Kelly TA; Snow RJ; Kennedy CA; Barton RW; Adams J; Krolikowski DA; Freeman DM; Campbell SJ; Ksiazek JF; Bachovchin WW
    J Med Chem; 1996 May; 39(10):2087-94. PubMed ID: 8642568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.
    Connolly BA; Sanford DG; Chiluwal AK; Healey SE; Peters DE; Dimare MT; Wu W; Liu Y; Maw H; Zhou Y; Li Y; Jin Z; Sudmeier JL; Lai JH; Bachovchin WW
    J Med Chem; 2008 Oct; 51(19):6005-13. PubMed ID: 18783201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization.
    Meadows SA; Edosada CY; Mayeda M; Tran T; Quan C; Raab H; Wiesmann C; Wolf BB
    Biochemistry; 2007 Apr; 46(15):4598-605. PubMed ID: 17381073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.
    Cheng JD; Dunbrack RL; Valianou M; Rogatko A; Alpaugh RK; Weiner LM
    Cancer Res; 2002 Aug; 62(16):4767-72. PubMed ID: 12183436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.
    Senten K; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
    J Med Chem; 2003 Nov; 46(23):5005-14. PubMed ID: 14584950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders.
    Gorrell MD
    Clin Sci (Lond); 2005 Apr; 108(4):277-92. PubMed ID: 15584901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties.
    Shibuya-Saruta H; Kasahara Y; Hashimoto Y
    J Clin Lab Anal; 1996; 10(6):435-40. PubMed ID: 8951616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural comparison of the bacterial PepX and human DPP-IV reveals sites for the design of inhibitors of PepX activity.
    Rigolet P; Xi XG; Rety S; Chich JF
    FEBS J; 2005 Apr; 272(8):2050-9. PubMed ID: 15819895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases.
    Van der Veken P; Senten K; Kertèsz I; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K
    J Med Chem; 2005 Mar; 48(6):1768-80. PubMed ID: 15771423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.
    Kang NS; Ahn JH; Kim SS; Chae CH; Yoo SE
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3716-21. PubMed ID: 17462890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New fluorinated pyrrolidine and azetidine amides as dipeptidyl peptidase IV inhibitors.
    Hulin B; Cabral S; Lopaze MG; Van Volkenburg MA; Andrews KM; Parker JC
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4770-3. PubMed ID: 16115768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and structure-activity relationships of piperidinone- and piperidine-constrained phenethylamines as novel, potent, and selective dipeptidyl peptidase IV inhibitors.
    Pei Z; Li X; von Geldern TW; Longenecker K; Pireh D; Stewart KD; Backes BJ; Lai C; Lubben TH; Ballaron SJ; Beno DW; Kempf-Grote AJ; Sham HL; Trevillyan JM
    J Med Chem; 2007 Apr; 50(8):1983-7. PubMed ID: 17367123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and use of 4-peptidylhydrazido-N-hexyl-1,8-naphthalimides as fluorogenic histochemical substrates for dipeptidyl peptidase IV and tripeptidyl peptidase I.
    Ivanov I; Tasheva D; Todorova R; Dimitrova M
    Eur J Med Chem; 2009 Jan; 44(1):384-92. PubMed ID: 18410982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.
    Ryabtsova O; Jansen K; Van Goethem S; Joossens J; Cheng JD; Lambeir AM; De Meester I; Augustyns K; Van der Veken P
    Bioorg Med Chem Lett; 2012 May; 22(10):3412-7. PubMed ID: 22525314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
    Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
    Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.